Compare Johnson & Johnson (JNJ) vs M&T Bank Corporation (MTB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs M&T Bank Corporation — how do they compare? Johnson & Johnson trades at $251.24 (market cap $609.12B), while M&T Bank Corporation trades at $247.28 (market cap $36.12B). The key difference: Johnson & Johnson is far larger — about 16.9× M&T Bank Corporation's market cap, and M&T Bank Corporation pays the higher dividend (2.41%). Which is the better fit depends on your goals.
| JNJ | MTB | |
|---|---|---|
Market Cap | $609.12B | $36.12B |
Volume | 6,156,228 | — |
Sector | Health | Financials |
52-Week High | $267.24 | $254.04 |
52-Week Low | $163.70 | $178.63 |
Enterprise Value | $642.06B | — |
Dividend Yield | 2.12% | 2.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $253.04, up 1.23% today, with a bullish technical signal from moving averages and strong earnings beats in Q1 and Q2 2026. The company raised 2026 guidance, with revenue projected to exceed $100 billion, supported by robust profitability margins and a solid dividend track record. Recent news highlights institutional buying and analyst optimism following Q2 results.
Outlook remains positive with a consensus price target of $279.33, offering ~10% upside. Key risks include MedTech segment volatility and rising debt levels, but JNJ's diversified healthcare portfolio and AAA balance sheet provide stability for long-term investors amid market fluctuations.
M&T Bank (MTB) trades at $249.24, down 1.89% on the day, yet maintains a bullish technical stance with strong moving average signals. The stock shows solid fundamentals with a P/E of 13.19 and net income margin of 30.85%, supported by three consecutive quarterly EPS beats. Recent Q2 2026 results highlighted record earnings, driven by loan growth and net interest income expansion, reinforcing positive analyst sentiment.
Outlook remains favorable with a consensus price target of $253.68, though risks include elevated debt levels and potential margin pressure from rising costs. The stock offers value with steady dividend payments and institutional backing, but investors should monitor interest rate sensitivity and competitive pressures in the regional banking sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →
